4
Changes in Ownership
Arcadia Biosciences, Inc. Filed Acc 0001209191-20-006290
Chief Commercial Officer bought 700 shares at $1.72 ($1,204)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Reiter Sarah Chief Commercial Officer | 2020-02-03 | Purchase | +700 | $1.72 | $1,204 | 3,800 | D |
| Derivatives | |||||||
| Reiter Sarah Chief Commercial Officer | 2020-02-03 | Grant or award · Stock Option (right to buy) | +50,000 | 121,705 | D | ||
| Open-market purchases · 700 sh · avg $1.72 · $1,204 | |||||||
Loading xslF345X03/doc4.xml…